This chapter about antithrombotic therapy in atrial fibrillation (AF) is part of the American
College of Chest Physicians Evidence-Based Guidelines Clinical Practice Guidelines (8th …

Background The risk of stroke varies considerably across different groups of patients with
atrial fibrillation (AF). Antithrombotic prophylaxis for stroke is associated with an increased …

This chapter about antithrombotic therapy in atrial fibrillation (AF) is part of the Seventh
ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based …

Background The risk of stroke is heterogeneous across different groups of patients with atrial
fibrillation (AF), being dependent on the presence of various stroke risk factors. We provide …

ContextPatients with nonvalvular atrial fibrillation (AF) have an increased risk of stroke and
other vascular events. ObjectiveTo compare the risk of vascular and bleeding events in …

In patients with atrial fibrillation (AF) and an intermediate risk of stroke (CHADS 2 score= 1),
available evidence from clinical trials is inconclusive and the present guidelines for the …

Atrial fibrillation (AF) is an important risk factor for stroke. According to a pooled analysis of
controlled clinical trials with warfarin, anticoagulation therapy reduces stroke risk by 62 …

Antithrombotic Therapy in Atrial Fibrillation - CHEST Skip to Main Content Advertisement
CHEST home Submit Log in Register Log in Submit Log in Subscribe Claim Cart (1 item)1 Skip …

In recent years the management of atrial fibrillation patients has progressively and
substantially changed because of the introduction of new treatments and the availability of …

Study Design During the last decade, many studies7–25 assessing the efficacy and safety of
different antithrombotic therapies for the prevention of stroke in AF have been published …